| Hyo Rang Lee Md Phd Corporation | |
|
4465 Wilshire Blvd Ste 303 Los Angeles CA 90010-3704 | |
| (213) 254-7103 | |
| (714) 220-2301 |
| Full Name | Hyo Rang Lee Md Phd Corporation |
|---|---|
| Speciality | Internal Medicine - Gastroenterology |
| Location | 4465 Wilshire Blvd, Los Angeles, California |
| Authorized Official Name and Position | Hyo Rang Lee (MD) |
| Authorized Official Contact | 2132547103 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Hyo Rang Lee Md Phd Corporation 4465 Wilshire Blvd Ste 303 Los Angeles CA 90010-3704 Ph: (213) 254-7103 | Hyo Rang Lee Md Phd Corporation 4465 Wilshire Blvd Ste 303 Los Angeles CA 90010-3704 Ph: (213) 254-7103 |
| NPI Number | 1003246018 |
|---|---|
| Provider Enumeration Date | 11/13/2013 |
| Last Update Date | 11/13/2013 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003246018 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | A78554 (California) | Primary |
News Archive
As the name suggests, you can't digest resistant starch so it ends up in the bowel in pretty much the same form it entered your mouth. As unlovely as that seems, once in the bowel this resistant starch does some important things, including decreasing bowel pH and transit time, and increasing the production of short-chain fatty acids. These effects promote the growth of good bugs while keeping bad bugs at bay.
Phylogica Ltd, a leading Australian peptide drug discovery company, and Pepscan Therapeutics, a Dutch biopharmaceutical firm focusing on protein mimicry technology, today announce that they have entered a Research Collaboration and Option Agreement to evaluate the combination of their complementary peptide technologies for drug discovery.
Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011.
Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the first patient has been dosed in a Phase 1/2 study of its vaccine candidate, CDX-1401, in patients with malignant solid tumors that express NY-ESO-1. CDX-1401 is a fully human monoclonal antibody designed to selectively deliver the NY-ESO-1 antigen to dendritic cells to generate a robust immune response against cancer cells expressing NY-ESO-1.
The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.
› Verified 9 days ago
Joseph I Kang Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3755 Beverly Blvd, Ste 301, Los Angeles, CA 90004 Phone: 323-664-7777 | |
Clinica Virgen De Guadalupe Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 985 W Vernon Ave, Los Angeles, CA 90037 Phone: 323-234-6300 | |
Ssg San Pedro Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5811 S San Pedro St, Los Angeles, CA 90011 Phone: 213-553-1800 | |
John L Sherman Md Amc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8635 W Third Street, Suite 790w, Los Angeles, CA 90048 Phone: 310-855-8081 Fax: 310-855-0438 | |
Altamed Medical Group Eapc Prop 99 Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 500 Citadel Dr, Ste 490, Los Angeles, CA 90040 Phone: 323-725-8751 Fax: 323-889-7399 | |
Altamed Health Services Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5425 Pomona Blvd, Los Angeles, CA 90022 Phone: 323-832-7527 Fax: 323-832-7599 | |
Apla Health & Wellness - David Geffen Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 611 S Kingsley Dr, Los Angeles, CA 90005 Phone: 213-201-1623 Fax: 213-201-1595 |